Valuation: Alpa Laboratories Limited

Market Cap 1.24B 12.98M 11.39M 10.75M 9.8M 18.36M 18.48M 129M 49.78M 635M 48.72M 47.67M 2.04B P/E 2025
11.2x
P/E 2026 6.51x
Enterprise Value -110M -1.15M -1.01M -953K -869K -1.63M -1.64M -11.41M -4.41M -56.28M -4.32M -4.23M -181M EV / Sales 2025
0.94x
EV / Sales 2026 -0.36x
Free-Float
42.71%
Yield 2025 *
-
Yield 2026 -
09-17 Alpa Laboratories Limited Announces Appointment of Diksha Jaswani as Company Secretary Cum Compliance Officer, Effective September 17, 2026 CI
08-13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-23 Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026 CI
07-08 Alpa Laboratories Limited Announces Resignation of Yashoda Patidar as Company Secretary and Compliance Officer, Effective July 26, 2026 CI
05-29 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
04-11 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
02-25 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
02-12 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
13/08/25 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
01/08/25 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
28/05/25 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/02/25 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
13/02/25 Alpa Laboratories Limited Appoints Srashti Chopra as Company Secretary and Compliance Officer CI
1 day+0.05%
1 week-0.42%
Current month-5.79%
1 month-4.82%
3 months-13.72%
6 months+4.27%
Current year-23.93%
1 week 58.3
Extreme 58.3
62.35
1 month 55.76
Extreme 55.76
65.3
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
93.85
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 28/05/2016
Director of Finance/CFO 65 -
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 01/01/1967
Director/Board Member - 28/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%-0.42%-36.38%-18.31% 12.97M
+0.12%+0.81%+13.81%+64.78% 46.37B
+1.09%+0.36%+39.50%+107.67% 37.26B
+2.00%+3.78%+18.12%+99.54% 12.53B
+0.05%+0.37%-7.29%+18.68% 11.8B
0.00%0.00%+18.72%+139.63% 8.97B
-1.34%-2.73%+27.67%+37.52% 7.09B
-2.07%-2.75%+17.20%+202.97% 7.01B
+1.43%+2.22%+43.10%-14.21% 7.29B
-2.45%-0.59%-51.49%+4.53% 4.99B
Average -0.11%+0.10%+8.30%+64.28% 14.33B
Weighted average by Cap. +0.32%+0.54%+19.50%+79.14%

Financials

2025 2026
Net sales 1.12B 11.74M 10.3M 9.72M 8.86M 16.6M 16.71M 116M 45.01M 574M 44.06M 43.11M 1.85B 1.06B 11.04M 9.7M 9.15M 8.34M 15.62M 15.72M 109M 42.36M 540M 41.46M 40.56M 1.74B
Net income 195M 2.04M 1.79M 1.69M 1.54M 2.88M 2.9M 20.18M 7.81M 99.56M 7.64M 7.48M 320M 150M 1.57M 1.38M 1.3M 1.18M 2.22M 2.23M 15.53M 6.01M 76.63M 5.88M 5.75M 246M
Net Debt -1.13B -11.76M -10.33M -9.74M -8.88M -16.64M -16.75M -117M -45.11M -575M -44.15M -43.19M -1.85B -1.35B -14.13M -12.4M -11.7M -10.67M -19.99M -20.12M -140M -54.19M -691M -53.04M -51.89M -2.22B
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
457
Date Price Change Volume
25/09/26 ₹59.10 +0.05% 125,298
24/09/26 ₹59.07 -2.19% 87,569
23/09/26 ₹60.39 -1.58% 64,455
22/09/26 ₹61.36 +2.92% 11,423
21/09/26 ₹59.62 +0.45% 8,962
  1. Stock Market
  2. Stocks
  3. ALPA Stock